流感病毒疫苗领域的最新进展:技术和试验的全面概述
Tristan W Clark1, John S Tregoning2, Helen Lister3
1School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Clinical microbiology reviews
|October 3, 2024
概括
英国的流感病毒感染率已恢复到大流行前的水平,增加了医疗保健需求. 流感疫苗的进步,包括mRNA和通用类型,为脆弱人群提供了新的保护策略.
科学领域:
- 公共卫生 公共卫生
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 英国的流感病毒感染 (2022/23) 已经恢复到大流行前的水平.
- 这种复苏给国家卫生服务 (NHS) 带来了巨大的负担,因为医疗保健利用率和住院病例的增加.
- 特定的人口结构,包括幼儿 (≤4岁),老年人 (≥65岁) 和患有先前疾病的个人,面临严重结局的最高风险.
研究的目的:
- 审查当前和新兴的流感病毒疫苗技术.
- 突出疫苗开发方面的进展,如mRNA和通用流感疫苗.
- 讨论这些新技术在减轻英国和全球流感负担方面的潜力.
主要方法:
- 关于流感疫苗技术的文献综述.
- 分析目前在英国和全球流感疫苗的情况.
- 探索正在开发的疫苗技术,包括mRNA和通用疫苗.
主要成果:
- 在英国,流感活动已恢复到COVID-19流行前的水平.
- 某些年龄组和患有潜在健康状况的个人不成比例地受到流感相关住院治疗的影响.
- 包括mRNA和通用疫苗在内的新型疫苗技术正在开发中,以加强保护.
结论:
- 流感疫苗技术的进步对于管理流感带来的持续公共卫生挑战至关重要.
- 新的疫苗方法,如mRNA和通用疫苗,有望对流感病毒提供更广泛和更好的保护.
- 疫苗接种方面的持续创新对于保护所有人群,特别是最脆弱的人群,免受流感对健康的重大影响至关重要.
相关概念视频
Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Vaccinations
Overview
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...


